The DOI matches its Crossref record; 200 of the 200 references it cites were found in a registry or an index.
Acetyl-CoA metabolism in cancer
Open accessAbstract
Few metabolites can claim a more central and versatile role in cell metabolism than acetyl coenzyme A (acetyl-CoA). Acetyl-CoA is produced during nutrient catabolism to fuel the tricarboxylic acid cycle and is the essential building block for fatty acid and isoprenoid biosynthesis. It also functions as a signalling metabolite as the substrate for lysine acetylation reactions, enabling the modulation of protein functions in response to acetyl-CoA availability. Recent years have seen exciting advances in our understanding of acetyl-CoA metabolism in normal physiology and in cancer, buoyed by new mouse models, in vivo stable-isotope tracing approaches and improved methods for measuring acetyl-CoA, including in specific subcellular compartments. Efforts to target acetyl-CoA metabolic enzymes are also advancing, with one therapeutic agent targeting acetyl-CoA synthesis receiving approval from the US Food and Drug Administration. In this Review, we give an overview of the regulation and cancer relevance of major metabolic pathways in which acetyl-CoA participates. We further discuss recent advances in understanding acetyl-CoA metabolism in normal tissues and tumours and the potential for targeting these pathways therapeutically. We conclude with a commentary on emerging nodes of acetyl-CoA metabolism that may impact cancer biology. Acetyl coenzyme A (acetyl-CoA) is a key metabolite in carbohydrate and lipid metabolism and plays a role in signalling through protein acetylation, and the dysregulation of these pathways is a hallmark of various cancers. In this Review, Guertin and Wellen give an overview of acetyl-CoA metabolism in health and in cancer and discuss emerging therapeutic strategies for targeting metabolic pathways involving acetyl-CoA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“acetylation relies on acetyl-CoA (Box 1, Figure I); a key node in various metabolic pathways which are commonly dysregulated in cancer [1–3].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Protein acetylation is intrinsically linked to metabolism due to its use of key metabolic intermediate acetyl-CoA [1,52].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx247 · Cited by 9,849
Ferroptosis: mechanisms, biology and role in disease
Jiang, X., Stockwell, B. R., & Conrad, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00324-8 · Cited by 7,973
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
Bersuker, K., Hendricks, J. M., Li, Z., Magtanong, L., Ford, B., Tang, P. H., Roberts, M. A., Tong, B., Maimone, T. J., Zoncu, R., et al. (2019) · Nature · doi:10.1038/s41586-019-1705-2 · Cited by 3,703
ATP-citrate lyase links cellular metabolism to histone acetylation
Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1164097 · Cited by 2,298
Self-citationTargeting Ferroptosis as a Vulnerability in Cancer
Lei, G., Zhuang, L., & Gan, B. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00459-0 · Cited by 2,252
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chang, C.-H., Curtis, J. D., Maggi, L. B., Faubert, B., Villarino, A. V., O’Sullivan, D., Huang, S. C.-C., van der Windt, G. J. W., Blagih, J., Qiu, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.016 · Cited by 2,204
Cellular Fatty Acid Metabolism and Cancer
Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese, R. V. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.017 · Cited by 2,123
DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer
Mao, C., Liu, X., Zhang, Y., Lei, G., Yan, Y., Lee, H., Koppula, P., Wu, S., Zhuang, L., Fang, B., et al. (2021) · Nature · doi:10.1038/s41586-021-03539-7 · Cited by 2,028
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020
Cited by
Sorted by citations
Items 201–300 of 301
Ponce-Garcia, F. M., Jenkins, Y. R., Assmann, V. D., Paul, S., Sharma, N. D., Moore, C., Ma, E. H., Diamanti, P., Hennequart, M., Blagih, J., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102275 · Cited by 1
“…as mean ± SEM. indicative of wider metabolic reshaping in these cells, where there is increased ACLY-mediated conversion of citrate to acetyl-CoA, that can fuel lipid associated pathways such as fatty acid synthesis and drive epigenetic remodelling through enhanced histone acetylation [30].”
circRNA-02213 Regulates Milk Fat Synthesis in Bovine Mammary Epithelial Cells via ACSS2
Sui, M., Duan, G., Wang, Z., Guo, S., & Fan, J. (2025) · Genes · doi:10.3390/genes16111351 · Cited by 1
Li, Z.-C., Hu, L., Jiang, M., Zhao, D., Lu, Y., Liu, Y., Li, B., & Jiang, M. (2025) · Animals · doi:10.3390/ani15223287 · Cited by 1
“Subsequently, fatty acid synthesis was driven by NADPH, ultimately promoting fatty acid deposition in adipose tissue and enhancing the animals’ resistance to external stimuli [37,38].”
Li, B., Zhou, K., Yin, A., Liu, Y. F., Wang, X., Cui, Y., Liu, F., Liu, Q., Zheng, H., Mu, Z., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67534-6 · Cited by 1
“Moreover, it should be noted that acetyl-CoA homeostasis and histone acetylation are intri-cately regulated through multiple interconnected pathways, including lipid metabolism, TCA cycle, mitochondrial function, and the sophis-ticatedpost-translationalproteinacetylation 75,76 .”
Feng, C., Liu, Q., Peng, J., Chunming, J., Pan, X., Liu, S., Geng, X., Zhai, J., Wu, M., Hao, S., et al. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116320 · Cited by 1
Cai, G., He, S., Pan, Y., Zhao, H., Li, H., Jiang, Y., Zhu, R., Zhang, Y., Lian, Z., Li, Z., et al. (2026) · Poultry Science · doi:10.1016/j.psj.2026.106671 · Cited by 1
Zhu, R., Na, J., Tan, X., Chen, X., Tian, X., Luo, J., Chen, Y., & Zhong, L. (2026) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s583017 · Cited by 1
“121,122 Acetyl-CoA is derived from multiple sources and can be generated through various metabolic reactions within cells, including those involving glucose, fatty acids, and amino acids.”
Crosstalk Between Cis-Regulatory Elements and Metabolism Reprogramming in Hepatocellular Carcinoma
Ren, Y., Tang, D., Ding, X., & He, M. (2026) · Cancers · doi:10.3390/cancers18061002 · Cited by 1
Wang, X.-M., Zhang, J., Yuan, J., Wen, L., Ying, T.-X., Xu, Z., Zhou, Z., Chen, S., Zhou, Q., Sheng, J.-H., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08575-7 · Cited by 1
“By directly supplying acetyl groups for lysine acetylation, it thus couples cellular metabolic fl ux to epigenetic regulation [43].”
The pivotal role of metabolism in shaping tumor-associated macrophages phenotype and function
Jun, M., Li, T., Shi, Y., Yin, H., Wu, W., Dong, X. W., He, X., & Lai, X. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116547 · Cited by 1
Emerging roles of ATP citrate lyase in kidney diseases: from pathogenic driver to therapeutic target
Wei, M., Tao, M., Tan, H., Jin, Z., Yang, Y., Xiao, Z., Li, G., & Chen, Y. (2026) · Renal Failure · doi:10.1080/0886022x.2026.2652826 · Cited by 1
The crosstalk between epigenetics and metabolism in the malignant cell
Țigu, A. B., Ivancuta, A., Constantinescu, C. S., Moisoiu, V., Grăjdieru, O., Cucoreanu, C., Nistor, M., Kegyes, D., Bancos, A., Tomacinschii, V., et al. (2026) · Discover Oncology · doi:10.1007/s12672-026-05082-1 · Cited by 2
“The Km for most of the HAT enzymes used by cells falls within the physiological range of acetyl-CoA concentrations found within the cell [170, 171].”
Ahmed, T., Zhang, H., Mushraf, G. M., Pan, Y., Zhang, Z., Sun, Z., Yin, M., Xu, X., Wu, X., Gao, Y., et al. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00784-2 · Cited by 1
“Because pyruvate metabolism through PDH is a major route for acetyl-CoA synthesis in mammalian cells (Guertin and Wellen, 2023), we fi rst tested whether pyruvate becomes essential for long-term QC1-treated cells.”
Mitochondria: from powerhouses of cells to hubs in antitumor immunity
Li, X., Shi, Y., Zhao, Y., Zhu, G., & Jin, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1852236 · Cited by 2
Wang, Y., Li, C., Liu, B., & Chen, X. (2026) · Cancer Bioscience · doi:10.1016/j.cbs.2026.100005 · Cited by 1
Eskandani, N. A., Mirzaee, D., Farani, M. R., Hatami, A., Hatami, M., Ghasemzaei, M., Ghoreishian, S. M., Hwang, S.-K., & Huh, Y. S. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115921 · Cited by 2
Lysine l ‐Lactylation: Bridging Metabolism, Chromatin and Disease
Malik, A., Dilawar, M., Liao, J., Zheng, J., Qian, Q., Xu, M., Lin, S., Zhu, X., 葛秋伟, Jin, L., et al. (2026) · Cell Proliferation · doi:10.1111/cpr.70262 · Cited by 1
Zhao, J., Xie, D.-K., Si, J., Fan, F., Gao, C., Yang, Z., Yu, H., Zhang, H., Hu, Y., Wang, L., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117922 · Cited by 1
Advances and insights in cancer metabolism and epigenetic reprogramming
Zeng, Y., Wang, P., & Ye, D. (2025) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2024-1379 · Cited by 1
Gismene, C., de Moraes, F. R., Bauermeister, A., da Costa, T. S., Calmon, M. F., Cerbino, L. E. D. A. P., Rahal, P., Góes, R. M., de Moraes, L. A. B., Tasić, L., et al. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c01029 · Cited by 1
Bi, Y., Brulois, K., Ayesha, A., Xiang, M., Ballet, R., Ocón, B., Dinh, T. T., Lazarus, N. H., Kunte, M., Ramos, G., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.07.014 · Cited by 1
FABP7 Progenitors are a Targetable Metabolic Root in the BRCA1 BreastPreprint
McCloskey, C. W., Zhang, B., Waas, M., Abazari, G., Vyas, F., Aliar, K., Tharmapalan, P., Kuttanamkuzhi, A., Narala, S., Cruikshank, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.02.565360 · Cited by 1
“Finally, acetyl-CoA is central to cellular metabolism and a critical mediator of cell state shifts as a substrate for glycolysis, fatty-acid synthesis, and histone acetylation 39,40 .”
BackgroundGilglioni, E. H., Li, A., St‐Pierre‐Wijckmans, W., Shen, T.-K., Pérez-Chávez, I., Hovhannisyan, G., Lisjak, M., Negueruela, J., Vandenbempt, V., Bauzá‐Martinez, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.01.569004 · Cited by 1
Xiong, W., Li, L., Tang, Q., Ge, J., Wang, D., Mo, Y., Wang, Y., Xiong, F., Yan, Q., Liao, Q., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3834927/v1 · Cited by 1
RetractedMa, L., Zhao, Y. H., Xiang, P., Chen, Q., Hassan, M., & Yu, C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.06.579210 · Cited by 2
Shui, X., Tian, L., Zhou, Y., & Zhao, B. (2024) · Research Square · doi:10.21203/rs.3.rs-3964435/v1 · Cited by 1
Screening and Analysis for Inhibitors of SHMT2 Enzyme ProteinPreprint
陈, 泊. (2023) · Research Square · doi:10.21203/rs.3.rs-2730768/v1
Metabolic regulation of epigenetic drug resistance
Snyder, N. W., & Meier, J. L. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01323-4
Xu, W., Fu, J., Ni, Y., Hu, Y., Tang, W., Fu, J., & Wang, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-2872361/v1
Sinha, A., Saini, K. K., Tripathi, K., Khan, M. A., Satrusal, S. R., Verma, A., Mandal, B., Rai, P., Meena, S., Nengroo, M. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.16.562466
KRAS mutation-selective requirement for ACSS2 in colorectal adenoma formation.Preprint
Chernoff, J., Budagyan, K., Cannon, A. C., Chatoff, A. G., Snyder, N. W., Kurimchak, A., & Duncan, J. S. (2024) · Research Square · doi:10.21203/rs.3.rs-3931415/v1
“An alternative route utilizes of acetyl-CoA synthetase short-chain family member 2 (ACSS2) to convert cytoplasmic acetate to acetyl-8 CoA 31,32 .”
MethodVeloso, A. B., Slegers, T., Schoenaker, J. M., Demeyer, S., den Bergh, S. V., Aertgeerts, M., Verhoeft, K. R., Schoenmaekers, Y., Meeuws, N., Bischops, I., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.03.583195
“Coenzyme A (acetyl-CoA) 15 ( Fig.”
Role of SREBP and related molecules in the development of endometrial cancer
Antmen, Ş. E., YALAZA, C., CANACANKATAN, N., AYTAN, H., TUNCEL, F., & ERTURK, S. E. (2024) · Indian Journal of Experimental Biology · doi:10.56042/ijeb.v62i04.4909
Sato, S., & Yamashita, T. (2024) · Translational Breast Cancer Research · doi:10.21037/tbcr-23-51
Zhang, X., Jiang, X., Wu, X., Yang, Y., Wang, J., Zheng, J., Zhou, M., & Chen, Q. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.09.607407
On the origin of cysteamine-induced duodenal cytotoxicity and type II ferroptosis
Schloss, J. V., & Szabó, S. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01551-7
“For CA, the shift of glycolysis between aerobic and anaerobic metabolism and associated CoA degradation (Czumaj et al. 2020; Guertin and Wellen 2023) is the likely target.”
Zhao, T., He, L., Wong, L. P., Mei, S., Xia, J., Xu, Y., Vranken, J. G. V., Mazzola, M. C., Chen, L., Rhee, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.25.650293
Bernard, M. J., Ruiz, A., Diaz, J. A., Nunley, N. M., Dove, R., Zhang, S., Lee, E., Heering, K. Y., Bopardikar, S., Gallardo, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.28.656673
Lin, L.-H., Lapi, F., Galuzzi, B., Vanoni, M., Alberghina, L., & Damiani, C. (2025) · bioRxiv · doi:10.1101/2025.08.01.668082 · Cited by 6
“Instead, a substantial portion may be diverted toward oxidative reactions mediated by IDH1, a well-known source of cytosolic α KG and NADPH [5, 6].”
Wang, S., Yushui, M. A., Lei, L., Pei, W., Jia, W., Jin, X., Qiang, J., Wang, C., Chentai, Q., Miaomiao, Z., et al. (2025) · PubMed Central · doi:10.19852/j.cnki.jtcm.2025.04.020
Clarke, C., Bijaoui, E. M. M., & Yang, Y. Y. (2025) · Research Square · doi:10.21203/rs.3.rs-6401817/v1
Unmasking cancer’s hidden nerve route with patient-derived organoids
Waters, K. M., Merchant, A. A., & Lin, D. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.08.008
Host EV–derived lipids promote malaria parasite development via mosquito fatty acid β-oxidationPreprint
Song, X., Cai, W., Wu, J., Liu, L., Gu, X., Zhou, H., Zhao, H. L., Tian, P., Xu, Q., Qian, K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.09.687433
Platelet mitochondria in fibrin rewire dental pulp stem cells' metabolism and function
Chen, S., Zhou, J., Wang, Y., Liu, X., Lv, H., & Zhou, Y. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.171191
Li, Y., Li, J., Wang, G., Yang, S., Liu, D., Wen, H., Zhang, M., Duan, C., Yu, M., Wang, S., et al. (2025) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2025.101474
Rahimi-Tamandegani, H., Marashi, A.-A., Ghavami, G., Mehrmohamadi, M., & Sardari, S. (2025) · Iranian Biomedical Journal · doi:10.61882/ibj.5178
“Lysine is catabolized into acetyl-CoA, a TCA cycle intermediate, potentially contributing to biosynthetic and energy-generating pathways under certain metabolic conditions [38] .”
López-Pascual, A., Elurbide, J., Valbuena-Goiricelaya, E., Latasa, M. U., Anaya, E., Adán-Villaescusa, E., Castelló-Uribe, B., Martínez‐Pérez, L. A., Uriarte, I., Arechederra, M., et al. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1765945
“In cancer cells, acetyl-CoA is supplied by PDH, ACSS2, and ACLY, while TCA cycle enzymes such as OGDH and the BCKDH complex generate additional acyl-CoA species that support non-acetyl acylations (Jo et al., 2020; Guertin and Wellen, 2023; Ghisletti and Russo, 2025).”
Ju, Q., Li, X., Wu, Z., Zhang, P., Chen, H., Ji, J., Gao, W., Zheng, Y., Yu, D., & Zhao, Y. (2025) · Environment & Health · doi:10.1021/envhealth.5c00524
“50 Substantial evidence indicates that acetyl-CoA is an important player in tumorigenesis.”
Huang, X., Chen, X., Wan, G., Yang, D., Zhu, D., Jia, L., & Zheng, J. (2024) · Figshare · doi:10.6084/m9.figshare.25271886
Metabolic control of DNA replication: beyond biosynthetic and bioenergetic needs
Dong, K., Pei, J., Liu, J., Li, Y., Wang, Y., & Feng, Y. (2025) · Epigenetics Insights · doi:10.48130/epi-0025-0015
Paul, D. (2025) · Springer eBooks · doi:10.1007/978-3-032-08808-6_12 · Cited by 2
Zhao, J.-Y., Ze-yu, Z., Qin, X.-J., Yan, J.-Y., Cai, K., Sun, X., Yao, Y., Lin, F. F., Shi, Y., Zhao, R., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8510072/v1
Jia, K., Zhang, S., He, Y., & Liang, L. (2026) · Human Mutation · doi:10.1155/humu/1500755
“Posttranslational modi fi cations like acetylation have been identi fi ed as important factors in cancer biology in addition to metabolic changes [22].”
Cytosolic acetyl-CoA: a metabolic regulator of mitophagy
Xiong, J. (2026) · Life Metabolism · doi:10.1093/lifemeta/loag002
LukS-PV targeting C5aR inhibits EMT in hepatocellular carcinoma via the BCL6/HDAC6/HSPD1 axis
Ding, P., Shi, L., Xu, X., Lu, B., Liu, G., Wang, Y., Nie, Z., Wang, X., Chang, W., Dai, Y., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-09640-9
“Recent studies have demonstrated that acetylation is crucially involved in the development and progression of tumors 36,37 .”
Tang, X., Liu, L., Gao, M., Duan, P., Li, S., Yuan, Z., Xia, Q., Xi, L., & Tan, Y. (2026) · Scientific Reports · doi:10.1038/s41598-026-38219-x
“The findings related to metabolic pathways— such as the conversion of pyruvate to acetyl-CoA and the synthesis of fatty acids from acetyl-CoA—highlight the metabolic adaptability of cancer cells 39,40 .”
The Acetyl‐CoA‐NLRX1 Axis Acts as a Key Player in Mitophagy and Drug Resistance
Jin, P., Hu, B., JIANG, J., & Xu, L. L. (2026) · MedComm – Oncology · doi:10.1002/mog2.70055
Liu, M., Jin, K., Qi, S., Chen, D., Han, Y., Xu, W., Wen, C., Wen, H., Liu, Y., He, B. H., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.17.712507
Cytosolic AcCoA: a metabolic signal bridging nutrient sensing and mitophagy
Chen, J., & Pan, X. (2026) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2026.01.007
He, X., Luo, M., Wang, C., Kong, L., Li, J., Tan, J., Chen, J., Nie, Y., Chen, H., Zou, Z., et al. (2026) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2026.101052
“Acetyl-CoA, a two-carbon end product of glucose, fatty acid, and amino acid catabolism, functions both as a central metabolic intermediate and as a key signaling nexus [13].”
Zhang, Z., Zhang, S., Luo, H., Zhang, Y., Liu, G., Liu, C., Qian, K., Xie, J., & Ou, Q. (2026) · Vibrational Spectroscopy · doi:10.1016/j.vibspec.2026.103914
Shi, Q., Bai, Y., Wang, J., Ru, M.-Y., Zhang, K., Guo, Y., Bai, Z.-T., & Shen, L. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00451-2
“ACC1 overexpression and hyperactivity in HCC tissues are correlated with tumor aggressiveness, making it a promising therapeutic target among DNL enzymes [29, 30].”
He, Q., Qu, M., Yang, Y., Sun, T., Bao, H., Shen, T., Yao, J., Xu, C., Wu, X., Liu, X., et al. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.152113
Wang, Z., Li, R., Zhao, X., Liu, M., Chen, Y., Zhao, Z., & Lu, C. (2026) · Planta · doi:10.1007/s00425-026-05016-9
“Acetyl-CoA may also be produced by the catabolism of certain amino acids, like the branched chain amino acids (BCAAs) leucine and isoleucine (Guertin and Wellen 2023).”
Cai, Z., Chen, X., 郑合勇, Zheng, R., Zheng, R., & Lin, W. (2026) · Open Life Sciences · doi:10.1515/biol-2025-1322
Liang, J., Li, K., Fang, S., Shi, Z., Zhang, W., Lu, Z., Zhang, X., Lu, M., Xu, H., & Xu, Z. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109075
Villareal, L., Liang, Y., Kwon, Y., Hui, S. T., & Xue, X. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102261
Han, Y., Zhang, C., Yao, W., Hong, Q., Tang, X., Zhu, Y., & Chen, N. (2026) · iLABMED · doi:10.1002/ila2.70064
“Consequently, targeting a single PTM often leads to compensatory activation of others, suggesting that combination therapies targeting multiple nodes of this network offer superior clinical efficacy [99].”
Yu, H., Gao, C., Xu, J., Wu, X., & Zhang, J. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.120352
Kulyaba, N. O., Bdzhola, A. V., Stasyshyn, A. R., Filonenko, V. V., & Bidiuk, D. (2026) · Biopolymers and Cell · doi:10.7124/bc.000b36
Tao, M., Ai, S., Gu, X., Wang, M., 孙明莉, & Wang, H.-L. (2026) · Current Research in Toxicology · doi:10.1016/j.crtox.2026.100312
Technological advancements in sirtuin analysis
Bishal, A., Manna, N., Pakhira, B., Khanra, S., & Sett, D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45380-9.00010-9
Platelet Proteome Links Metabolism to Reactivity in Essential Thrombocythemia
Guerrero-Carreño, X., Smits, S., Lasso, A. E., Samiotaki, M. K., Calabuig-Navarro, V., Iborra, F. J., Rantanen, F., Álvarez‐Larrán, A., Angona, A., Bellosillo, B., et al. (2026) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2026.101617
Zeng, C., Zhu, J., Lu, R., Wu, P., Li, X., Li, F., Peng, C., 周应芳, & Xue, Q. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003770 · Cited by 1
“[46] Inhibiting ACC1 has anti-cancer effects in several malignancies, including hepatocellular carcinoma.”
Hayashi, Y., Kinoshita, K., Lu, T.-M., Tseng, H.-Y., Maki, K., Kimura, S., Yano, E., Saeki, A., Yasukochi, A., Minami, K., et al. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102416
“In addition, ACC1 activity influences histone modification because acetyl-CoA serves as a key substrate for protein acetylation, including histones [9 — 14].”
Yang, R., Zhan, Y., Deng, Z., Zhang, J., Chen, S., Zhang, Y., Fu, H., Meng, X., Wu, J., Gu, Y., et al. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.07.034
Wang, M. M., Bai, Y., Guo, Y. X., Shen, X., Yang, J., Miao, H., Zhang, X., Wang, P., Kang, A., & Dang, E. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.122190
The interplay of metabolism and epigenetics in cardiovascular diseases
Yuan, X., & Li, X. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34186-1.00020-7
Zhang, S., Zhang, N., Zhang, X., Liu, Y., Feng, Y., Xiang, J., Zhang, J., Ma, H., Lu, Y., & Zhang, T. (2026) · Microbiome · doi:10.1186/s40168-026-02475-w
“…release of Acetyl-CoA, but rather points to a potential route by which dysbiotic salivary microbiota may reshape exchangeable metabolic intermediates, such as acetate, other short-chain fatty acids, or related organic acids, that can subsequently enter host Acetyl-CoA metabolism [16, 46–49].”
Chen, J., Ji, Y.-C., Wu, C.-H., Chen, J.-G., Zeng, H.-X., Xie, C., Fang, J., & Zhuang, S. (2026) · Gut · doi:10.1136/gutjnl-2026-338754
Liu, Y., Xiao, Y., Chen, Y., Huang, C., Lin, F., Zhuang, Q., Li, H., Lin, P., Tang, L., & Li, J. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02753-z
Ligand-dependent interdomain rearrangements drive catalysis by acetyl-CoA synthetases
Li, M., Zhou, M., & Marmorstein, R. (2026) · Structure · doi:10.1016/j.str.2026.07.009
Ying, K., Xing, X., Wang, Z., Tian, Q., Zhang, Q., Liu, C., & Zheng, L. (2026) · Bioresource Technology · doi:10.1016/j.biortech.2026.135590
Short-chain fatty acids act as metabolic and epigenetic regulators in CAR T cell therapy
Ma, M., Zhou, C.-X., Shi, X., Zhu, J.-M., & Duan, C. (2026) · Molecular Therapy Oncology · doi:10.1016/j.omton.2026.201322
“125,126 The mechanistic entry points of the two SCFAs are therefore potentially non-overlapping, but this characterization is itself inferential, derived from comparing independent experimental systems rather than from direct head-to-head measurement in the same cellular context.…”
Hao, Z., Kadier, D., Qian, W., Wang, Z., Zhang, C., Shen, Y., Yuan, W., Zhu, Y., Wu, Q., Li, L., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10567364/v1
GarcÃa-Bocanegra, I., Urbano‐Gámez, J. D., Pérez-Cardona, A., Barrios, L., Somoza‐Ramírez, M. I., Vicioso, L., Susacasa, E. P., Córdoba, G. D., Acebal‐Blanco, M. M., Sendra‐Portero, F., et al. (2026) · NMR in Biomedicine · doi:10.1002/nbm.70386
Li, H., Deng, H., Liu, J., Zhang, Q., Cheng, L., Wan, L., Gao, M., Han, Y., Wang, X., Zhou, X., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.09.002
Zhang, J., Gao, S., & Kong, Q. (2026) · Trends Open · doi:10.1016/j.treopn.2026.08.011
Ren, Y., Wang, Q., Qu, X., & 车晓芳 (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1917412
“Tumor cells frequently reprogram acyl-CoA metabolism by altering the expression and metabolic fl ux of key enzymes across these three pathways to cope with proliferative and oxidative stress (8).”
Acetyl-CoA–dependent processes are preferentially supported by local metabolite synthesis
Supplee, J., Costa‐Pinheiro, P., Wessendorf-Rodriguez, K. A., Stransky, S., Yang, Q., Demetriadou, C., Murali, N., Joy, L., Pennise, J. L., Marcinkiewicz, M. M., et al. (2026) · Science Advances · doi:10.1126/sciadv.aee4935
“Acetyl-CoA is also required for acetylation reactions, including histone acetylation within the nucleus ( 4 ).”
InfluentialSelf-citationCitrate-derived acetyl-CoA partitioning as a metabolic-epigenetic checkpoint in cancer
Komninou, D., & Papanikolaou, N. A. (2026) · Metabolism Open · doi:10.1016/j.metop.2026.100496 · Cited by 1
Epigenomic Remodeling by Lipid Metabolism: A Cross-Disease Perspective on Cancer and Brain Disorders
Rafique, A., Farooq, A., Cho, C. E., & Bakovic, M. (2026) · Genes · doi:10.3390/genes17091134
“…acetyl-CoA inside mitochondria; mitochondrial acetyl-CoA itself does not freely cross the inner mitochondrial membrane, so its carbon can influence cytosolic and nuclear acetyl-CoA pools only indirectly through exportable intermediates and shuttle pathways, depending on cellular state [7].”
InfluentialHagedorn, G. A., Spieser, J., Hirai, N., Sato, Y., Valentine, J., Jiang, H., Wang, W., Czyzyk-Krzeska, M., & Patra, K. C. (2026) · Science Advances · doi:10.1126/sciadv.aeh7186
“Supplementation of acetoacetate but not acetate [which primarily increases cytosolic acetyl-CoA ( 46 )] increased mitochondrial length in Dbt KO KG cells (Fig.”
Lipid metabolic regulation and targeting strategies in the brain metastasis tumor microenvironment
Huang, X., Xian, X., Zhang, H., Wang, S., & Fu, B. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189729
Miao, Z., Hu, M., Li, K., Liu, J., Lin, W., Xiong, W., Zhang, H., & Zhang, Y. (2026) · Cancer Bioscience · doi:10.1016/j.cbs.2026.100011
KSHV vIRF3–PKM2 interaction induces SMAD5 acetylation, promoting Kaposi’s sarcoma progression
Kim, Y. J., Lim, J., Lee, J. J., Kumar, A., Kannappan, S., Zhang, J., Kim, S., Kim, H., Kim, K. K., Tóth, Z., et al. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01849-2
Palmitate puts ACLY in shape to reprogram macrophages
Huang, B., & Yin, C. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.118061
Research progress on ATP-citrate lyase and its inhibitors: a metabolic-epigenetic perspective
Liu, Q., Sun, H., & Dai, L. (2026) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2026.2744392
“As a major source of cytoplasmic acetyl-coA, it serves as a major hub connecting mitochondrial energy metabolism with cytoplasmic anabolism 32 . the catalytic reaction of AclY follows an ordered mechanism.”
Fujii, A., & Yoshimura, Y. (2026) · Nutrients · doi:10.3390/nu18213481
Mechanism of koumine in treating ulcerative colitis by targeting TSPO to regulate energy metabolism
Xiong, B., Lai, S., Cai, S., Lin, S., Zhang, X., 苏衍萍, Zhuang, T., Xu, Y., Yang, J., & Yu, C. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179475
Metadata
- Authors
- Guertin, D. A., & Wellen, K. E.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- University of Pennsylvania (US)
- Corresponding author
- Guertin, David A.
- Wellen, Kathryn E.
- Venue
- Nature Reviews Cancer
- Published
- 2023-01-19
- Volume
- 23
- Issue
- 3
- Pages
- 156-172
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC11137663
- OpenAlex
- W4317436153
- Cited by
- 303
- References
- 200
- Citations by year
- 2026: 85 · 2025: 120 · 2024: 69 · 2023: 29
- FWCI
- 9.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature reviews. Cancer (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion, cc-by)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA174761, R01CA248315, R01CA228339, R01CA262055)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK094004, R01DK116005, R01DK127175)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- acetyl-CoA metabolism, cancer metabolism, TCA cycle, fatty acid synthesis, isoprenoid biosynthesis, lysine acetylation, protein acetylation, metabolic signalling, stable isotope tracing
- MeSH terms
- Acetyl Coenzyme A, Animals, Disease Models, Animal, Humans, Neoplasms, Mice, Metabolic Networks and Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review